- Home
- SITC vs AVTX Comparison
SITC vs AVTX Comparison
Compare SITC & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.38
HOLD
Current Price
$17.62
Company Overview
Basic Information| Metric | SITC | AVTX |
|---|---|---|
| Founded | 1965 | 2011 |
| Country | United States | United States |
| Employees | 155 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.5M | 328.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SITC | AVTX |
|---|---|---|
| Price | $5.38 | $17.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $8.00 | ★ $40.57 |
| AVG Volume (30 Days) | 410.9K | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 123.63% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.09 | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $5.24 | $3.43 |
| 52 Week High | $12.61 | $24.27 |
Technical Indicators
Market Signals| Indicator | SITC | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 52.60 |
| Support Level | $5.26 | $13.47 |
| Resistance Level | $5.55 | $19.39 |
| Average True Range (ATR) | 0.13 | 1.90 |
| MACD | -0.01 | 0.24 |
| Stochastic Oscillator | 20.48 | 42.94 |
Price Performance
Historical Comparison SITC
AVTX
About SITC SITE Centers Corp.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.